sur EUROFINS SCIENTIFIC SE (isin : FR0014000MR3)
Eurofins Finalizes Acquisition of Element's Life Sciences Testing Services
On October 1, 2026, Eurofins Scientific, a leader in bioanalytical testing, completed the acquisition of Life Sciences Testing Services from Element Materials Technology in North America. The deal, initially announced on July 20, 2026, was closed for USD 400 million. This strategic move enhances Eurofins' network in key US and Canadian regions.
The acquired business, featuring 27 laboratories and employing 750 staff, provides testing services across Biopharma, Environmental, and Food sectors. It is expected to generate over USD 150 million in annual revenue, aligning with Eurofins' average profitability.
This addition will integrate with Eurofins' existing North American operations, allowing clients broader access to Eurofins' services. CEO Dr. Gilles Martin emphasizes the synergies in their expanded and digitized lab platforms. The transition will ensure consistent service for all customers.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de EUROFINS SCIENTIFIC SE